Navegar por los elementos (20655 total)

https://socictopen.socict.org/files/to_import/pdfs/f538e4e08aab597530ff9fbcbf95cb3d.pdf
We read with interest the paper from Navarro-Millan about the use of anakinra in severe COVID-19 patients (1). On the other hand, there is the issue of patients treated with anakinra for their underlying condition and who develop COVID-19 (2).

Position: 4428 (105 views)

Formatos de Salida

atom, dcmes-xml, json, omeka-xml, rss2